Skip to main content

Table 2 Clinical data of 28 patients with SFT

From: Solitary fibrous tumor – clinicopathologic, immunohistochemical and molecular analysis of 28 cases

Case Age Sex Size (cm) Site Margin status Treatment Local recurrence MET Follow-up
1 21 F 9 Abdomen Neg SE Y, multiple Y DOD, 52 yrs
2 74 F 9 Calf Neg SE NA NA NA
3 59 M 13 Pelvis Neg SE; CT after MET Y Y NED, MET 48 mo
4 55 F 9.5 Retro-peritoneum Neg SE; CT + RT after MET N Y DOD, 13 mo
5 84 F 10 Para-tracheal Neg SE NA NA NED, 48 mo
6 68 F 17 Lung Neg SE NA NA NA
7 39 F 3 Thigh Neg SE N N NED, 36 mo
8 34 M 4.1 Cheek Neg SE N N NED, 27 mo
9 75 F 12 Neck Neg SE N N NED, 26 mo
10 50 F 10 Uterus Neg SE N N NED, 33 mo
11 52 F 4.7 Biceps Neg SE N N NED, 32 mo
12 52 M 6.3 Lung Pos SE N N NED, 17 mo
13 56 M 16 Pelvis Neg SE N N NED, 12 mo
14 53 F 4.5 Pleura Neg SE N N NED, 21 mo
15 71 M NA Lung NA SE NA NA NA
16 39 M 2 Mastoid Pos EMB + SE; SE + RT after recurrence Y N NED, 7 mo after treatment of recurrent disease
17 44 F 2.5 Orbit Neg SE Y N NA
18 55 M 13 Lung Neg SE N N NED, 9 yrs
19 63 M 4 Lung Neg SE NA NA NA
20 45 F 7.5 Mesenterium Neg SE N N NED, 10 yrs
21 33 F 9 Calf Pos SE N N NED, 23 mo
22 67 F NA Buttock NA SE N N NA
23 68 F 14 Pleura NA SE N N NED, 8 mo
24 76 M 7 Abdomen Neg SE NA NA NA
25 69 F NA Lung NA SE NA NA NA
26 43 M 9.5 Back Neg SE NA NA NA
27 42 F 1.6 Head Neg SE NA NA NA
28 42 F 5.5 Knee Neg SE N N NED, 9 yrs
  1. NA = data not available; SE = surgical excision; MET = metastasis; EMB = embolization; DOD = died of disease; NED = no evidence of disease; AWD = alive with disease; CT = chemotherapy; RT = radiotherapy; Y = yes; N = no.